文献速递心力衰竭与心肌病

炎症性肠病患者心力衰竭风险:瑞典全国人群研究

Risk of heart failure in inflammatory bowel disease: a Swedish population-based study.
PubMed 文献 · Eur Heart J · 2024-01-01

中位随访12.4年间,炎症性肠病患者心衰风险高于参考个体(aHR 1.19,95%CI 1.15-1.23),确诊后≥20年风险仍升高,各亚型均见风险增加,同胞对照分析关联略减弱(aHR 1.10,95%CI 1.03-1.19)。

要点

  • 炎症性肠病患者心衰风险较一般人群中度升高,aHR 1.19。
  • 风险在确诊后≥20年仍显著,每130例患者至该时点多1例心衰。
  • 克罗恩病、溃疡性结肠炎及未分型炎症性肠病均见风险增加。

核心结论

  • 炎症性肠病患者确诊后≥20年内心衰风险较一般人群中度升高。

研究设计与样本

  • 采用灵活参数生存模型估计调整风险比及标准化累积发病率,含95%CI。

主要发现

  • 炎症性肠病患者心衰风险高于参考个体(aHR 1.19,95%CI 1.15-1.23)。
  • 确诊后≥20年风险仍显著升高,至该时点每130例炎症性肠病患者多1例心衰。
  • 亚型风险均升高:克罗恩病(发生率46.9 vs 34.4;aHR 1.28,95%CI 1.20-1.36)、溃疡性结肠炎(50.1 vs 39.7;aHR 1.14,95%CI 1.09-1.19)、未分型(60.9 vs 39.0;aHR 1.28,95%CI 1.16-1.42)。
  • 同胞对照分析关联略减弱(炎症性肠病:aHR 1.10,95%CI 1.03-1.19)。

临床怎么用

  • 对炎症性肠病患者应长期关注心衰风险,尤其在确诊后≥20年仍持续升高。
  • 各炎症性肠病亚型均需警惕心衰,未分型患者发生率数值最高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Dysregulation of inflammatory and immune responses has been implicated in the pathogenesis of heart failure (HF). But even if inflammation is a prerequisite for inflammatory bowel disease (IBD), little is known about HF risk in IBD. METHODS: In this Swedish nationwide cohort, patients with biopsy-confirmed IBD were identified between 1969 and 2017 [n = 81 749, Crohn's disease (CD, n = 24 303), ulcerative colitis (UC, n = 45 709), and IBD-unclassified (IBD-U, n = 11 737)]. Each patient was matched with up to five general population reference individuals (n = 382 190) and IBD-free full siblings (n = 95 239) and followed until 31 December 2019. Flexible parametric survival models estimated the adjusted hazard ratio (aHR) and standardized cumulative incidence for HF, with 95% confidence intervals (CI). RESULTS: There were 5582 incident HF identified in IBD patients (incidence rate [IR]: 50.3/10 000 person-years) and 20 343 in reference individuals (IR: 37.9) during a median follow-up of 12.4 years. IBD patients had a higher risk of HF than reference individuals (aHR 1.19, 95% CI 1.15-1.23). This increased risk remained significant ≥20 years after IBD diagnosis, leading to one extra HF case per 130 IBD patients until then. The increased risk was also observed across IBD subtypes: CD (IR: 46.9 vs. 34.4; aHR 1.28 [1.20-1.36]), UC (IR: 50.1 vs. 39.7; aHR 1.14 [1.09-1.19]), and IBD-U (IR: 60.9 vs. 39.0; aHR 1.28 [1.16-1.42]). Sibling-controlled analyses showed slightly attenuated association (IBD: aHR 1.10 [1.03-1.19]). CONCLUSIONS: Patients with IBD had a moderately higher risk of developing HF for ≥20 years after IBD diagnosis than the general population.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Sun, Yao, Olén, et al. Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. Eur Heart J. 2024. PMID: 38771865. doi:10.1093/eurheartj/ehae338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。